Schematic diagram illustrating some of the major abnormalities related to sensitized D1R-signaling and associated to LID

Schematic diagram illustrating some of the major abnormalities related to sensitized D1R-signaling and associated to LID. In PD, the loss of striatal dopamine leads to sensitization of D1Rs on the striatonigral MSNs of the direct pathway. Emerging evidence indicates that, if persistent, this phenomenon results in the appearance of dyskinesia. D1R sensitization may be caused by augmented D1R expression at the cell surface. Chronic administration of l-DOPA promotes the release of BDNF from corticostriatal neurons, leading to activation of TrκB receptors and increased expression of D3Rs, specifically in striatonigral MSNs. Direct interaction with D3Rs is likely to increase the levels of membrane-bound D1Rs, thereby exacerbating D1R sensitization and dyskinetic behavior. In line with this possibility, D3R antagonists have been found to counteract LID in experimental models of PD. Sensitized D1R transmission may also be caused by increased levels of adenylyl cyclase 5 (AC 5) in striatonigral MSNs. Increased responsiveness of the D1R/Gαolf/AC5 machinery to l-DOPA results in augmented synthesis of cAMP and hyper-activation of PKA and DARPP-32. Pharmacological inhibition of PKA, or genetic inactivation of DARPP-32 have been shown to reduce LID. Abnormal PKA/DARPP-32 signaling increases the phosphorylation of GluR1. This effect promotes the excitability of MSNs and may participate in the loss of corticostriatal LTD and depotentiation associated to LID. Sensitized D1R-mediated transmission leads also to activation of ERK, which controls transcriptional and translational processes. Both pharmacological and genetic suppression of ERK signaling counteracts the development and expression of LID. In the nucleus, PKA/DARPP-32 and ERK/MSK1 signaling leads to phosphorylation of CREB and histone H3, and increased expression of immediate early genes and prodynorphin. Reduced expression/activity of ΔfosB efficiently counteracts LID. Activation of ERK promotes mTORC1-dependent signaling, thereby accelerating mRNA translation. Blockade of mTORC1 with rapamycin has been found to attenuate the development of LID. Red color indicates receptors or signaling components whose targeting reduces LID. See text for abbreviations.
Schematic diagram illustrating some of the major abnormalities related to sensitized D1R-signaling and associated to LID

Publication

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. (2011) Michael Feyder, et al. Front Behav Neurosci. 2011;5:71. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates BDNF BDNF ncbigene_symbol BDNF 627
Homo sapiens Primates BDNF BDNF ncbigene_synonym BDNF-AS 497258
Homo sapiens Primates DIR DIR ncbigene_synonym AVPR2 554
Homo sapiens Primates AC ADCY famplex_relations ADCY1 107
Homo sapiens Primates AC ADCY famplex_relations ADCY2 108
Homo sapiens Primates AC ADCY famplex_relations ADCY3 109
Homo sapiens Primates AC ADCY famplex_relations ADCY4 196883
Homo sapiens Primates AC ADCY famplex_relations ADCY5 111
Homo sapiens Primates AC ADCY famplex_relations ADCY6 112
Homo sapiens Primates AC ADCY famplex_relations ADCY7 113
Homo sapiens Primates AC ADCY famplex_relations ADCY8 114
Homo sapiens Primates AC ADCY famplex_relations ADCY9 115
Homo sapiens Primates AC ADCY famplex_relations ADCY10 55811
Homo sapiens Primates TrkB TRKB ncbigene_synonym NTRK2 4915
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates DARPP-32 DARPP-32 ncbigene_synonym PPP1R1B 84152
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKAR1A 5573
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKAR1B 5575
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKAR2A 5576
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKAR2B 5577
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKACA 5566
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKACB 5567
Homo sapiens Primates PKA/DARPP-32– PKA famplex_relations PRKACG 5568
Homo sapiens Primates P-ERK ERK ncbigene_synonym EPHB2 2048
Homo sapiens Primates P-ERK ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates P-ERK ERK famplex_relations MAPK3 5595
Homo sapiens Primates MTORC1 MTORC1 famplex_relations MTOR 2475
Homo sapiens Primates MTORC1 MTORC1 famplex_relations RPTOR 57521
Homo sapiens Primates P-MSK1 MSK1 ncbigene_synonym RPS6KA5 9252
Homo sapiens Primates PDyn PDYN ncbigene_symbol PDYN 5173
Homo sapiens Primates zif268 ZIF268 ncbigene_synonym EGR1 1958
Homo sapiens Primates P-CREB CREB ncbigene_synonym CREB1 1385
Homo sapiens Primates P-CREB CREB famplex_relations CREB3 10488
Homo sapiens Primates P-CREB CREB famplex_relations CREB5 9586
Homo sapiens Primates P-CREB CREB famplex_relations CREB3L1 90993
Homo sapiens Primates P-CREB CREB famplex_relations CREB3L2 64764
Homo sapiens Primates P-CREB CREB famplex_relations CREB3L3 84699
Homo sapiens Primates P-CREB CREB famplex_relations CREB3L4 148327
Homo sapiens Primates P-CREB CREB famplex_relations CREM 1390
Homo sapiens Primates P-CREB CREB famplex_relations ATF1 466
Homo sapiens Primates P-CREB CREB famplex_relations ATF2 1386
Homo sapiens Primates c-fos C-FOS ncbigene_synonym FOS 2353
Homo sapiens Primates arc ARC ncbigene_symbol ARC 23237
Homo sapiens Primates arc ARC ncbigene_synonym NOL3 8996
Homo sapiens Primates GluR1 GLUR1 ncbigene_synonym GRIA1 2890

Chemical mentions

Word Match MeSH Name ChEBI
L-DOPA Levodopa mesh:D007980 L-dopa chebi:15765

Disease mentions

Word Match MeSH Name DOID